New analyses on terbinafine susceptibility and MOB-015 published in Journal of Fungi

Data ReadoutpositiveMOB-015Positive

AI Analysis

Summary

Moberg Pharma announced publication of new analyses showing potent antifungal activity of terbinafine (MOB-015) against dermatophytes causing onychomycosis with achieved mycological cure.

Outcome Details

New analyses published demonstrating potent antifungal activity of terbinafine against dermatophytes causing onychomycosis with mycological cure achieved

Importance:4/10

Sentiment:

0.60

antifungaldermatologypublicationonychomycosisterbinafine

Related Companies

$MOB

Read the original article

Published by PR Newswire Biotech on October 5, 2026 6:26 AM

Read Original